题名

Add-on Subanesthetic Ketamine in Electroconvulsive Therapy: A Case Report of a Patient with Bipolar Depression

DOI

10.4103/TPSY.TPSY_16_20

作者

Tien-Wei Hsu；Chih-Chuan Pan；Chen-Hsiu Chen；Cheng-Ho Chang

关键词
期刊名称

台灣精神醫學

卷期/出版年月

34卷2期（2020 / 06 / 01）

页次

94 - 95

内容语文

英文
主题分类 醫藥衛生 > 社會醫學
参考文献
  1. Lee, WG,Chang, SS(2009).Monitoring the seizure efficacy during electroconvulsive therapy.Taiwan J Psychiatry,23,4-13.
    連結：
  2. Conway, CR,George, MS,Sackeim, HA(2017).Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough.JAMA Psychiatry,74,9-10.
  3. Fava, M(2003).Diagnosis and definition of treatment-resistant depression.Biol Psychiatry,53,649-659.
  4. Fava, M,Freeman, MP,Flynn, M(2018).Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).Mol Psychiatry
  5. Fava, M,Freeman, MP,Flynn, M(2018).Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).Brain Stimul,11,75-84.
  6. Fond, G,Loundou, A,Rabu, C(2014).Ketamine administration in depressive disorders: a systematic review and meta-analysis.Psychopharmacology,231,3663-3676.
  7. Li, DJ,Wang, FC,Chu, CS(2017).Significant treatment effect of add-on ketamine anesthesia in electroconvulsive therapy in depressive patients: a meta-analysis.Eur Neuropsychopharmacol,27,29-41.
  8. Loo, C(2018).Can we confidently use ketamine as a clinical treatment for depression?.Lancet Psychiatry,5,11-12.
  9. Nemeroff, CB(2018).Ketamine: quo vadis?.Am J Psychiatry,175,297-299.
  10. Ritter, P,Findeis, H,Bauer, M(2020).Ketamine in the treatment of depressive episodes.Pharmacopsychiatry,53,45-50.
  11. Romeo, B,Choucha, W,Fossati, P(2015).Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression.Psychiatry Res,230,682-688.
  12. Singh, JB,Fedgchin, M,Daly, EJ(2016).A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression.Am J Psychiatry,173,816-826.
  13. Thomas, RK,Baker, G,Lind, J(2018).Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness.J Psychopharmacol,32,1110-1117.
  14. Weiner, RD,Reti, IM(2017).Key updates in the clinical application of electroconvulsive therapy.Int Rev Psychiatry,29,54-62.
print cancel